Physician profile
Roma Patel
NPI 1063724797
$163,902.43
in general payments reported to CMS, 2019-2025
21 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $14.99 · 2021: $1,468 · 2022: $6,437 · 2023: $32K · 2024: $50K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $65K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Food and Beverage: $17K · Honoraria: $17K · Travel and Lodging: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,778.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,145.82 |
| Food and Beverage | $17,310.75 |
| Honoraria | $17,000.00 |
| Travel and Lodging | $13,324.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $65,871.63 | 2019-2025 | Hydrus Microstent, Voyager Dslt, Clareon |
| Abbvie INC. | $34,906.76 | 2021-2025 | |
| New World Medical,INC. | $25,705.95 | 2021-2025 | Kahook Dual Blade, Streamline, Ahmed Glaucoma Valve |
| Glaukos Corporation | $16,040.94 | 2019-2025 | Travoprost Intraocular Implant - Idose, Idose Tr, Istent Trabecular Micro-Bypass Stent System |
| Bausch & Lomb Americas INC. | $9,425.48 | 2023-2025 | Vyzulta, Envista Mx60 Iol, Xiidra |
| Sight Sciences, INC. | $7,323.41 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Dompe Farmaceutici S.P.A. | $2,250.00 | 2024 | |
| Allergan, INC. | $497.65 | 2019-2022 | |
| Alcon Research LLC | $490.00 | 2023 | |
| Ivantis, INC | $421.17 | 2021 | |
| Aerie Pharmaceuticals, INC. | $311.90 | 2021 | |
| Nova Eye, INC. | $180.32 | 2023-2025 | |
| Carl Zeiss Meditec USA, INC. | $129.84 | 2022-2024 | Artevo 800, Atlas 500 |
| Novo Nordisk INC | $102.17 | 2025 | Rivfloza |
| Johnson & Johnson Surgical Vision, INC. | $62.18 | 2022-2023 | Healon Duet Pro, Tecnis Simplicity |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $56.60 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $34.45 | 2021 | |
| Dompe US, INC. | $30.86 | 2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.25 | 2021 | |
| Beaver-Visitec International, INC. | $21.00 | 2023 | |
| Harrow Eye, LLC | $16.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roma Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.